Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function [Cellular and Molecular]
ASPET
OCTOBER 8, 2024
Significance Statement This study examines the effects of clinically relevant small molecule BCR-ABL tyrosine kinase inhibitors (TKIs) on platelet activity. Overall, these new insights around the effects of ABL TKIs on platelet function could inform the development of targeted therapies with reduced hematologic toxicities.
Let's personalize your content